Neuropsychopharmacology. 2025 Sep 25. doi: 10.1038/s41386-025-02241-w. Online ahead of print.
ABSTRACT
Deep brain stimulation (DBS) targeting the nucleus accumbens (NAc) is a promising therapeutic intervention for treatment-resistant neuropsychiatric disorders such as depression, anxiety, and addiction. However, the molecular mechanisms underlying the clinical efficacy of NAc DBS remain largely unknown. One approach to address this question is by performing spatial gene expression analysis on cells located in different regions of the same circuit following NAc DBS. In this study, we utilized high-resolution spatial transcriptomics (Stereo-seq) to investigate gene expression changes induced by NAc DBS in the mouse brain. Mice were randomly allocated to receive continuous electrical stimulation (0.1 mA, 130 Hz) or sham treatment (electrode implanted, no electrical stimulation given) for one week, and subsequent Stereo-seq analysis identified differentially expressed genes (DEGs) across various brain regions. Functional enrichment analysis highlighted changes in synaptic and neuroplasticity processes as well as stress and inflammatory responses in the NAc circuit. Single-cell resolution mapping further identified key molecular players, including Nlgn1, Snca, Pde10a, and Syt1, particularly in glutamate receptor-expressing neurons in the NAc. These genes are critical for synaptic plasticity and neurotransmitter release, and have been implicated in various psychiatric disorders. These findings shed light on the molecular underpinnings of NAc DBS and provide insights into its therapeutic potential in modulating neural circuits associated with neuropsychiatric disorders.
PMID:40999234 | DOI:10.1038/s41386-025-02241-w
Recent Comments